FindTrial
Sign In

Clinical study of S-ketamine in the treatment of perinatal depression

Clinical study of S-ketamine in reducing depression and anti-inflammation and immune protection after abortion curettage

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058731
Enrollment
Unknown
Registered
2022-04-15
Start date
2022-04-17
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal depression

Interventions

Three groups:Drug treatment

Sponsors

Nanjing Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Missed abortion in early pregnancy (confirmed by clinical records and ultrasonic results); 2. Childbearing age (18-45 years old); 3. It is planned to perform uterine cleansing under intravenous general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Contraindications to the use of dizocine, S-ketamine and propofol; 2. Serious contraindication of intravenous general anesthesia.

Design outcomes

Primary

MeasureTime frame
VAS and EPDS score;—

Countries

China

Contacts

Public ContactShanwu Feng

Nanjing Maternal and child Health Care Hospital

shanwufeng@163.com+86 13921426351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026